# Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

> **NCT06842056** · — · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06842056
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-15
- **Primary completion:** 2030-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842056, "Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06842056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*